{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:20:06Z","timestamp":1793319606816,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117809","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:01:44Z","timestamp":1770969704000},"page":"117809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gamabufotalin impedes NSCLC progression by inhibiting the mitochondrial factor CHCHD2 and modulating XAF1 expression"],"prefix":"10.1016","volume":"247","author":[{"given":"Yisi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-0942","authenticated-orcid":false,"given":"Weijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.bcp.2026.117809_b0005","doi-asserted-by":"crossref","first-page":"32056","DOI":"10.1073\/pnas.2005877117","article-title":"Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms","volume":"117","author":"Aras","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bcp.2026.117809_b0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/cdd.2014.194","article-title":"CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation","volume":"22","author":"Liu","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117809_b0015","doi-asserted-by":"crossref","first-page":"15500","DOI":"10.1038\/ncomms15500","article-title":"Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c","volume":"8","author":"Meng","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.117809_b0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bcp.2026.117809_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2025.01.032","article-title":"Carbon Ion Radiation Therapy with Pencil Beam Scanning for Stage III Non-Small Cell Lung Cancer: Toxicity Profiles, Survival Outcomes, and Prognostic Indicators","volume":"122","author":"Ma","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.bcp.2026.117809_b0035","first-page":"387","article-title":"Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management","volume":"75","author":"Borgeaud","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bcp.2026.117809_b0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21147\/j.issn.1000-9604.2024.04.06","article-title":"Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors","volume":"36","author":"He","year":"2024","journal-title":"Chin. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0045","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1038\/s41467-025-59744-9","article-title":"Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial","volume":"16","author":"Arrieta","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117809_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076625","article-title":"Illness trajectories of incurable solid cancers","volume":"384","author":"Geijteman","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bcp.2026.117809_b0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer","volume":"54","author":"Rivera-Concepcion","year":"2022","journal-title":"Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.bcp.2026.117809_b0060","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bcp.2026.117809_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156094","article-title":"A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1","volume":"135","author":"Zheng","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bcp.2026.117809_b0070","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.tibs.2020.05.006","article-title":"Detecting Protein-Small Molecule Interactions Using Limited Proteolysis-Mass Spectrometry (LiP-MS)","volume":"45","author":"Pepelnjak","year":"2020","journal-title":"Trends Biochem. Sci"},{"issue":"3","key":"10.1016\/j.bcp.2026.117809_b0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41596-022-00771-x","article-title":"Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications","volume":"18","author":"Malinovska","year":"2023","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.1016\/j.bcp.2026.117809_b0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41594-022-00837-0","article-title":"Global, in situ analysis of the structural proteome in individuals with Parkinson's disease to identify a new class of biomarker","volume":"29","author":"Mackmull","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117809_b0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00535-024-02145-4","article-title":"Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis","volume":"59","author":"Wang","year":"2024","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0090","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/s41467-023-37576-9","article-title":"Farrerol directly activates the deubiqutinase UCHL3 to promote DNA repair and reprogramming when mediated by somatic cell nuclear transfer","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2026.117809_b0095","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.bcp.2026.117809_b0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/acscentsci.2c01424","article-title":"Macrophage Inactivation by Small Molecule Wedelolactone via Targeting sEH for the Treatment of LPS-Induced Acute Lung Injury","volume":"9","author":"Zhang","year":"2023","journal-title":"ACS Cent. Sci."},{"issue":"W1","key":"10.1016\/j.bcp.2026.117809_b0105","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117809_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.bcp.2026.117809_b0115","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.117809_b0120","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/bioinformatics\/btv458","article-title":"NRGsuite: a PyMOL plugin to perform docking simulations in real time using FlexAID","volume":"31","author":"Gaudreault","year":"2015","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.bcp.2026.117809_b0125","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.bcp.2026.117809_b0130","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.apsb.2025.02.027","article-title":"Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12890-020-1079-0","article-title":"CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression","volume":"20","author":"Yin","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117809_b0140","first-page":"329","article-title":"Value of CHCHD2 as a potential marker of non-small cell lung cancer: analysis of 60 cases","volume":"38","author":"Xu","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"27","key":"10.1016\/j.bcp.2026.117809_b0145","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.7150\/jca.31158","article-title":"CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients","volume":"10","author":"Yao","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/ol.2022.13355","article-title":"Interferon-\u03b1 and its effects on cancer cell apoptosis","volume":"24","author":"Shi","year":"2022","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2026.117809_b0155","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13200","article-title":"IFN\u2011\u03b3 induces apoptosis in gemcitabine\u2011resistant pancreatic cancer cells","volume":"29","author":"Kong","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.117809_b0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(03)00148-4","article-title":"LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members","volume":"195","author":"Zhang","year":"2003","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11033-024-09347-2","article-title":"XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress","volume":"51","author":"Chen","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"21","key":"10.1016\/j.bcp.2026.117809_b0170","first-page":"7068","article-title":"Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas","volume":"63","author":"Byun","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117809_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1476-4598-13-203","article-title":"Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK\u03b2\/NF-\u03baB signaling pathway in lung cancer cells","volume":"13","author":"Yu","year":"2014","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2026.117809_b0180","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1007\/s12035-024-04090-y","article-title":"Loss of CHCHD2 Stability Coordinates with C1QBP\/CHCHD2\/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction","volume":"61","author":"Ren","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0185","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41467-025-57142-9","article-title":"Dysregulation of mitochondrial \u03b1-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117809_b0190","article-title":"CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis. Markers"},{"issue":"11","key":"10.1016\/j.bcp.2026.117809_b0195","first-page":"6426","article-title":"CHCHD2 decreases docetaxel sensitivity in breast cancer via activating MMP2","volume":"24","author":"Ma","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117809_b0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12020-023-03393-9","article-title":"What is the role of CHCHD2 in adrenal tumourigenesis?","volume":"81","author":"Karapanagioti","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2026.117809_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1581850","article-title":"Molecular insights into glioblastoma progression: role of CHCHD2P9 in tumor heterogeneity and prognosis","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.bcp.2026.117809_b0210","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41388-025-03321-3","article-title":"Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma by upregulating VEGFA","volume":"44","author":"Xu","year":"2025","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2026.117809_b0215","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5565","article-title":"CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia\u2011induced invasion and therapeutic resistance","volume":"63","author":"Lumibao","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2026.117809_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101623","article-title":"MNRR1 is a driver of ovarian cancer progression","volume":"29","author":"Chehade","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2026.117809_b0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jot.2024.05.001","article-title":"XAF1 promotes osteoclast apoptosis by antagonizing the XIAP-caspase axis","volume":"47","author":"Zhang","year":"2024","journal-title":"J Orthop Translat"},{"issue":"8\u20139","key":"10.1016\/j.bcp.2026.117809_b0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbaexp.2006.08.003","article-title":"Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells","volume":"1759","author":"Zhang","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"47","key":"10.1016\/j.bcp.2026.117809_b0235","doi-asserted-by":"crossref","first-page":"76551","DOI":"10.18632\/oncotarget.10388","article-title":"Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2026.117809_b0240","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12732","article-title":"Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794","volume":"53","author":"Lan","year":"2020","journal-title":"Cell Prolif."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:06:51Z","timestamp":1779109611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0006295226001401"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117809","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gamabufotalin impedes NSCLC progression by inhibiting the mitochondrial factor CHCHD2 and modulating XAF1 expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117809"}}